Clinical Trials Browser

Interventional × Carcinoma, Medullary × ponatinib × Clear all

NCT03838692 2021-10-13

Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer

Phase 2 Withdrawn

Carcinoma, Medullary